Pre-order Enquiry
Request Free Sample
Global Hospital Injectable Drugs Market Size, Status and Forecast 2021-2027
SKU ID : QYR-17771420 | Publishing Date : 22-Mar-2021 | No. of pages : 129
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Hospital Injectable Drugs Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital Injectable Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Generic Sterile Injectables
1.2.3 Sterile Intravenous (IV) Solutions
1.3 Market by Application
1.3.1 Global Hospital Injectable Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Oncology
1.3.3 Anesthesia
1.3.4 Anti-Infectives
1.3.5 Parenteral Nutrition
1.3.6 Cardiovascular Diseases
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hospital Injectable Drugs Market Perspective (2016-2027)
2.2 Hospital Injectable Drugs Growth Trends by Regions
2.2.1 Hospital Injectable Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hospital Injectable Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Hospital Injectable Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Hospital Injectable Drugs Industry Dynamic
2.3.1 Hospital Injectable Drugs Market Trends
2.3.2 Hospital Injectable Drugs Market Drivers
2.3.3 Hospital Injectable Drugs Market Challenges
2.3.4 Hospital Injectable Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital Injectable Drugs Players by Revenue
3.1.1 Global Top Hospital Injectable Drugs Players by Revenue (2016-2021)
3.1.2 Global Hospital Injectable Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Hospital Injectable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hospital Injectable Drugs Revenue
3.4 Global Hospital Injectable Drugs Market Concentration Ratio
3.4.1 Global Hospital Injectable Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital Injectable Drugs Revenue in 2020
3.5 Hospital Injectable Drugs Key Players Head office and Area Served
3.6 Key Players Hospital Injectable Drugs Product Solution and Service
3.7 Date of Enter into Hospital Injectable Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital Injectable Drugs Breakdown Data by Type
4.1 Global Hospital Injectable Drugs Historic Market Size by Type (2016-2021)
4.2 Global Hospital Injectable Drugs Forecasted Market Size by Type (2022-2027)
5 Hospital Injectable Drugs Breakdown Data by Application
5.1 Global Hospital Injectable Drugs Historic Market Size by Application (2016-2021)
5.2 Global Hospital Injectable Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Hospital Injectable Drugs Market Size (2016-2027)
6.2 North America Hospital Injectable Drugs Market Size by Type
6.2.1 North America Hospital Injectable Drugs Market Size by Type (2016-2021)
6.2.2 North America Hospital Injectable Drugs Market Size by Type (2022-2027)
6.2.3 North America Hospital Injectable Drugs Market Size by Type (2016-2027)
6.3 North America Hospital Injectable Drugs Market Size by Application
6.3.1 North America Hospital Injectable Drugs Market Size by Application (2016-2021)
6.3.2 North America Hospital Injectable Drugs Market Size by Application (2022-2027)
6.3.3 North America Hospital Injectable Drugs Market Size by Application (2016-2027)
6.4 North America Hospital Injectable Drugs Market Size by Country
6.4.1 North America Hospital Injectable Drugs Market Size by Country (2016-2021)
6.4.2 North America Hospital Injectable Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Hospital Injectable Drugs Market Size (2016-2027)
7.2 Europe Hospital Injectable Drugs Market Size by Type
7.2.1 Europe Hospital Injectable Drugs Market Size by Type (2016-2021)
7.2.2 Europe Hospital Injectable Drugs Market Size by Type (2022-2027)
7.2.3 Europe Hospital Injectable Drugs Market Size by Type (2016-2027)
7.3 Europe Hospital Injectable Drugs Market Size by Application
7.3.1 Europe Hospital Injectable Drugs Market Size by Application (2016-2021)
7.3.2 Europe Hospital Injectable Drugs Market Size by Application (2022-2027)
7.3.3 Europe Hospital Injectable Drugs Market Size by Application (2016-2027)
7.4 Europe Hospital Injectable Drugs Market Size by Country
7.4.1 Europe Hospital Injectable Drugs Market Size by Country (2016-2021)
7.4.2 Europe Hospital Injectable Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Hospital Injectable Drugs Market Size (2016-2027)
8.2 Asia-Pacific Hospital Injectable Drugs Market Size by Type
8.2.1 Asia-Pacific Hospital Injectable Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hospital Injectable Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hospital Injectable Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Hospital Injectable Drugs Market Size by Application
8.3.1 Asia-Pacific Hospital Injectable Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hospital Injectable Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hospital Injectable Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Hospital Injectable Drugs Market Size by Region
8.4.1 Asia-Pacific Hospital Injectable Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hospital Injectable Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hospital Injectable Drugs Market Size (2016-2027)
9.2 Latin America Hospital Injectable Drugs Market Size by Type
9.2.1 Latin America Hospital Injectable Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Hospital Injectable Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Hospital Injectable Drugs Market Size by Type (2016-2027)
9.3 Latin America Hospital Injectable Drugs Market Size by Application
9.3.1 Latin America Hospital Injectable Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Hospital Injectable Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Hospital Injectable Drugs Market Size by Application (2016-2027)
9.4 Latin America Hospital Injectable Drugs Market Size by Country
9.4.1 Latin America Hospital Injectable Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Hospital Injectable Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital Injectable Drugs Market Size (2016-2027)
10.2 Middle East & Africa Hospital Injectable Drugs Market Size by Type
10.2.1 Middle East & Africa Hospital Injectable Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hospital Injectable Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hospital Injectable Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Hospital Injectable Drugs Market Size by Application
10.3.1 Middle East & Africa Hospital Injectable Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hospital Injectable Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hospital Injectable Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Hospital Injectable Drugs Market Size by Country
10.4.1 Middle East & Africa Hospital Injectable Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hospital Injectable Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Hospira (Pfizer Inc.)
11.1.1 Hospira (Pfizer Inc.) Company Details
11.1.2 Hospira (Pfizer Inc.) Business Overview
11.1.3 Hospira (Pfizer Inc.) Hospital Injectable Drugs Introduction
11.1.4 Hospira (Pfizer Inc.) Revenue in Hospital Injectable Drugs Business (2016-2021)
11.1.5 Hospira (Pfizer Inc.) Recent Development
11.2 Baxter
11.2.1 Baxter Company Details
11.2.2 Baxter Business Overview
11.2.3 Baxter Hospital Injectable Drugs Introduction
11.2.4 Baxter Revenue in Hospital Injectable Drugs Business (2016-2021)
11.2.5 Baxter Recent Development
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Company Details
11.3.2 Fresenius Kabi Business Overview
11.3.3 Fresenius Kabi Hospital Injectable Drugs Introduction
11.3.4 Fresenius Kabi Revenue in Hospital Injectable Drugs Business (2016-2021)
11.3.5 Fresenius Kabi Recent Development
11.4 Sandoz (Novartis)
11.4.1 Sandoz (Novartis) Company Details
11.4.2 Sandoz (Novartis) Business Overview
11.4.3 Sandoz (Novartis) Hospital Injectable Drugs Introduction
11.4.4 Sandoz (Novartis) Revenue in Hospital Injectable Drugs Business (2016-2021)
11.4.5 Sandoz (Novartis) Recent Development
11.5 Hikma Pharmaceuticals PLC
11.5.1 Hikma Pharmaceuticals PLC Company Details
11.5.2 Hikma Pharmaceuticals PLC Business Overview
11.5.3 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Introduction
11.5.4 Hikma Pharmaceuticals PLC Revenue in Hospital Injectable Drugs Business (2016-2021)
11.5.5 Hikma Pharmaceuticals PLC Recent Development
11.6 Dr. Reddy’s Laboratories Ltd
11.6.1 Dr. Reddy’s Laboratories Ltd Company Details
11.6.2 Dr. Reddy’s Laboratories Ltd Business Overview
11.6.3 Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Introduction
11.6.4 Dr. Reddy’s Laboratories Ltd Revenue in Hospital Injectable Drugs Business (2016-2021)
11.6.5 Dr. Reddy’s Laboratories Ltd Recent Development
11.7 Grifols
11.7.1 Grifols Company Details
11.7.2 Grifols Business Overview
11.7.3 Grifols Hospital Injectable Drugs Introduction
11.7.4 Grifols Revenue in Hospital Injectable Drugs Business (2016-2021)
11.7.5 Grifols Recent Development
11.8 Nichi-Iko Group (Sagent)
11.8.1 Nichi-Iko Group (Sagent) Company Details
11.8.2 Nichi-Iko Group (Sagent) Business Overview
11.8.3 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Introduction
11.8.4 Nichi-Iko Group (Sagent) Revenue in Hospital Injectable Drugs Business (2016-2021)
11.8.5 Nichi-Iko Group (Sagent) Recent Development
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Details
11.9.2 Teva Pharmaceutical Business Overview
11.9.3 Teva Pharmaceutical Hospital Injectable Drugs Introduction
11.9.4 Teva Pharmaceutical Revenue in Hospital Injectable Drugs Business (2016-2021)
11.9.5 Teva Pharmaceutical Recent Development
11.10 Otsuka
11.10.1 Otsuka Company Details
11.10.2 Otsuka Business Overview
11.10.3 Otsuka Hospital Injectable Drugs Introduction
11.10.4 Otsuka Revenue in Hospital Injectable Drugs Business (2016-2021)
11.10.5 Otsuka Recent Development
11.11 B.Braun
11.11.1 B.Braun Company Details
11.11.2 B.Braun Business Overview
11.11.3 B.Braun Hospital Injectable Drugs Introduction
11.11.4 B.Braun Revenue in Hospital Injectable Drugs Business (2016-2021)
11.11.5 B.Braun Recent Development
11.12 JW Life Science
11.12.1 JW Life Science Company Details
11.12.2 JW Life Science Business Overview
11.12.3 JW Life Science Hospital Injectable Drugs Introduction
11.12.4 JW Life Science Revenue in Hospital Injectable Drugs Business (2016-2021)
11.12.5 JW Life Science Recent Development
11.13 Auromedics
11.13.1 Auromedics Company Details
11.13.2 Auromedics Business Overview
11.13.3 Auromedics Hospital Injectable Drugs Introduction
11.13.4 Auromedics Revenue in Hospital Injectable Drugs Business (2016-2021)
11.13.5 Auromedics Recent Development
11.14 Sanofi
11.14.1 Sanofi Company Details
11.14.2 Sanofi Business Overview
11.14.3 Sanofi Hospital Injectable Drugs Introduction
11.14.4 Sanofi Revenue in Hospital Injectable Drugs Business (2016-2021)
11.14.5 Sanofi Recent Development
11.15 Gland Pharma
11.15.1 Gland Pharma Company Details
11.15.2 Gland Pharma Business Overview
11.15.3 Gland Pharma Hospital Injectable Drugs Introduction
11.15.4 Gland Pharma Revenue in Hospital Injectable Drugs Business (2016-2021)
11.15.5 Gland Pharma Recent Development
11.16 Endo International PLC
11.16.1 Endo International PLC Company Details
11.16.2 Endo International PLC Business Overview
11.16.3 Endo International PLC Hospital Injectable Drugs Introduction
11.16.4 Endo International PLC Revenue in Hospital Injectable Drugs Business (2016-2021)
11.16.5 Endo International PLC Recent Development
11.17 Sichuan Kelun Pharmaceutical
11.17.1 Sichuan Kelun Pharmaceutical Company Details
11.17.2 Sichuan Kelun Pharmaceutical Business Overview
11.17.3 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Introduction
11.17.4 Sichuan Kelun Pharmaceutical Revenue in Hospital Injectable Drugs Business (2016-2021)
11.17.5 Sichuan Kelun Pharmaceutical Recent Development
11.18 Cisen Pharmaceutical
11.18.1 Cisen Pharmaceutical Company Details
11.18.2 Cisen Pharmaceutical Business Overview
11.18.3 Cisen Pharmaceutical Hospital Injectable Drugs Introduction
11.18.4 Cisen Pharmaceutical Revenue in Hospital Injectable Drugs Business (2016-2021)
11.18.5 Cisen Pharmaceutical Recent Development
11.18 Shijiazhuang No. 4 Pharmaceutical
.1 Shijiazhuang No. 4 Pharmaceutical Company Details
.2 Shijiazhuang No. 4 Pharmaceutical Business Overview
.3 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Introduction
.4 Shijiazhuang No. 4 Pharmaceutical Revenue in Hospital Injectable Drugs Business (2016-2021)
.5 Shijiazhuang No. 4 Pharmaceutical Recent Development
11.20 Shandong Hualu Pharmaceutical
11.20.1 Shandong Hualu Pharmaceutical Company Details
11.20.2 Shandong Hualu Pharmaceutical Business Overview
11.20.3 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Introduction
11.20.4 Shandong Hualu Pharmaceutical Revenue in Hospital Injectable Drugs Business (2016-2021)
11.20.5 Shandong Hualu Pharmaceutical Recent Development
11.21 CR Double-Crane
11.21.1 CR Double-Crane Company Details
11.21.2 CR Double-Crane Business Overview
11.21.3 CR Double-Crane Hospital Injectable Drugs Introduction
11.21.4 CR Double-Crane Revenue in Hospital Injectable Drugs Business (2016-2021)
11.21.5 CR Double-Crane Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Hospital Injectable Drugs Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Hospital Injectable Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Generic Sterile Injectables
Table 3. Key Players of Sterile Intravenous (IV) Solutions
Table 4. Global Hospital Injectable Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Hospital Injectable Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hospital Injectable Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Hospital Injectable Drugs Market Share by Regions (2016-2021)
Table 8. Global Hospital Injectable Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Hospital Injectable Drugs Market Share by Regions (2022-2027)
Table 10. Hospital Injectable Drugs Market Trends
Table 11. Hospital Injectable Drugs Market Drivers
Table 12. Hospital Injectable Drugs Market Challenges
Table 13. Hospital Injectable Drugs Market Restraints
Table 14. Global Hospital Injectable Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Hospital Injectable Drugs Market Share by Players (2016-2021)
Table 16. Global Top Hospital Injectable Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital Injectable Drugs as of 2020)
Table 17. Ranking of Global Top Hospital Injectable Drugs Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Hospital Injectable Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hospital Injectable Drugs Product Solution and Service
Table 21. Date of Enter into Hospital Injectable Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hospital Injectable Drugs Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Hospital Injectable Drugs Revenue Market Share by Type (2016-2021)
Table 25. Global Hospital Injectable Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Hospital Injectable Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Hospital Injectable Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Hospital Injectable Drugs Revenue Market Share by Application (2016-2021)
Table 29. Global Hospital Injectable Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Hospital Injectable Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Hospital Injectable Drugs Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Hospital Injectable Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Hospital Injectable Drugs Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Hospital Injectable Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Hospital Injectable Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Hospital Injectable Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Hospital Injectable Drugs Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Hospital Injectable Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Hospital Injectable Drugs Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Hospital Injectable Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Hospital Injectable Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Hospital Injectable Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Hospital Injectable Drugs Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Hospital Injectable Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Hospital Injectable Drugs Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Hospital Injectable Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hospital Injectable Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Hospital Injectable Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Hospital Injectable Drugs Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Hospital Injectable Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Hospital Injectable Drugs Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Hospital Injectable Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Hospital Injectable Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Hospital Injectable Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Hospital Injectable Drugs Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Hospital Injectable Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Hospital Injectable Drugs Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Hospital Injectable Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hospital Injectable Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Hospital Injectable Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 61. Hospira (Pfizer Inc.) Company Details
Table 62. Hospira (Pfizer Inc.) Business Overview
Table 63. Hospira (Pfizer Inc.) Hospital Injectable Drugs Product
Table 64. Hospira (Pfizer Inc.) Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million)
Table 65. Hospira (Pfizer Inc.) Recent Development
Table 66. Baxter Company Details
Table 67. Baxter Business Overview
Table 68. Baxter Hospital Injectable Drugs Product
Table 69. Baxter Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million)
Table 70. Baxter Recent Development
Table 71. Fresenius Kabi Company Details
Table 72. Fresenius Kabi Business Overview
Table 73. Fresenius Kabi Hospital Injectable Drugs Product
Table 74. Fresenius Kabi Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million)
Table 75. Fresenius Kabi Recent Development
Table 76. Sandoz (Novartis) Company Details
Table 77. Sandoz (Novartis) Business Overview
Table 78. Sandoz (Novartis) Hospital Injectable Drugs Product
Table 79. Sandoz (Novartis) Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million)
Table 80. Sandoz (Novartis) Recent Development
Table 81. Hikma Pharmaceuticals PLC Company Details
Table 82. Hikma Pharmaceuticals PLC Business Overview
Table 83. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product
Table 84. Hikma Pharmaceuticals PLC Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million)
Table 85. Hikma Pharmaceuticals PLC Recent Development
Table 86. Dr. Reddy’s Laboratories Ltd Company Details
Table 87. Dr. Reddy’s Laboratories Ltd Business Overview
Table 88. Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Product
Table 89. Dr. Reddy’s Laboratories Ltd Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million)
Table 90. Dr. Reddy’s Laboratories Ltd Recent Development
Table 91. Grifols Company Details
Table 92. Grifols Business Overview
Table 93. Grifols Hospital Injectable Drugs Product
Table 94. Grifols Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million)
Table 95. Grifols Recent Development
Table 96. Nichi-Iko Group (Sagent) Company Details
Table 97. Nichi-Iko Group (Sagent) Business Overview
Table 98. Nichi-Iko Group (Sagent) Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million)
Table 99. Nichi-Iko Group (Sagent) Recent Development
Table 100. Teva Pharmaceutical Company Details
Table 101. Teva Pharmaceutical Business Overview
Table 102. Teva Pharmaceutical Hospital Injectable Drugs Product
Table 103. Teva Pharmaceutical Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million)
Table 104. Teva Pharmaceutical Recent Development
Table 105. Otsuka Company Details
Table 106. Otsuka Business Overview
Table 107. Otsuka Hospital Injectable Drugs Product
Table 108. Otsuka Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million)
Table 109. Otsuka Recent Development
Table 110. B.Braun Company Details
Table 111. B.Braun Business Overview
Table 112. B.Braun Hospital Injectable Drugs Product
Table 113. B.Braun Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million)
Table 114. B.Braun Recent Development
Table 115. JW Life Science Company Details
Table 116. JW Life Science Business Overview
Table 117. JW Life Science Hospital Injectable Drugs Product
Table 118. JW Life Science Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million)
Table 119. JW Life Science Recent Development
Table 120. Auromedics Company Details
Table 121. Auromedics Business Overview
Table 122. Auromedics Hospital Injectable Drugs Product
Table 123. Auromedics Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million)
Table 124. Auromedics Recent Development
Table 125. Sanofi Company Details
Table 126. Sanofi Business Overview
Table 127. Sanofi Hospital Injectable Drugs Product
Table 128. Sanofi Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million)
Table 129. Sanofi Recent Development
Table 130. Gland Pharma Company Details
Table 131. Gland Pharma Business Overview
Table 132. Gland Pharma Hospital Injectable Drugs Product
Table 133. Gland Pharma Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million)
Table 134. Gland Pharma Recent Development
Table 135. Endo International PLC Company Details
Table 136. Endo International PLC Business Overview
Table 137. Endo International PLC Hospital Injectable Drugs Product
Table 138. Endo International PLC Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million)
Table 139. Endo International PLC Recent Development
Table 140. Sichuan Kelun Pharmaceutical Company Details
Table 141. Sichuan Kelun Pharmaceutical Business Overview
Table 142. Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product
Table 143. Sichuan Kelun Pharmaceutical Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million)
Table 144. Sichuan Kelun Pharmaceutical Recent Development
Table 145. Cisen Pharmaceutical Company Details
Table 146. Cisen Pharmaceutical Business Overview
Table 147. Cisen Pharmaceutical Hospital Injectable Drugs Product
Table 148. Cisen Pharmaceutical Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million)
Table 149. Cisen Pharmaceutical Recent Development
Table 150. Shijiazhuang No. 4 Pharmaceutical Company Details
Table 151. Shijiazhuang No. 4 Pharmaceutical Business Overview
Table 152. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product
Table 153. Shijiazhuang No. 4 Pharmaceutical Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million)
Table 154. Shijiazhuang No. 4 Pharmaceutical Recent Development
Table 155. Shandong Hualu Pharmaceutical Company Details
Table 156. Shandong Hualu Pharmaceutical Business Overview
Table 157. Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product
Table 158. Shandong Hualu Pharmaceutical Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million)
Table 159. Shandong Hualu Pharmaceutical Recent Development
Table 160. CR Double-Crane Company Details
Table 161. CR Double-Crane Business Overview
Table 162. CR Double-Crane Hospital Injectable Drugs Product
Table 163. CR Double-Crane Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million)
Table 164. CR Double-Crane Recent Development
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hospital Injectable Drugs Market Share by Type: 2020 VS 2027
Figure 2. Generic Sterile Injectables Features
Figure 3. Sterile Intravenous (IV) Solutions Features
Figure 4. Global Hospital Injectable Drugs Market Share by Application: 2020 VS 2027
Figure 5. Oncology Case Studies
Figure 6. Anesthesia Case Studies
Figure 7. Anti-Infectives Case Studies
Figure 8. Parenteral Nutrition Case Studies
Figure 9. Cardiovascular Diseases Case Studies
Figure 10. Hospital Injectable Drugs Report Years Considered
Figure 11. Global Hospital Injectable Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Hospital Injectable Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Hospital Injectable Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Hospital Injectable Drugs Market Share by Regions (2022-2027)
Figure 15. Global Hospital Injectable Drugs Market Share by Players in 2020
Figure 16. Global Top Hospital Injectable Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital Injectable Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Hospital Injectable Drugs Revenue in 2020
Figure 18. Global Hospital Injectable Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Hospital Injectable Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Hospital Injectable Drugs Market Share by Type (2016-2027)
Figure 22. North America Hospital Injectable Drugs Market Share by Application (2016-2027)
Figure 23. North America Hospital Injectable Drugs Market Share by Country (2016-2027)
Figure 24. United States Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Hospital Injectable Drugs Market Share by Type (2016-2027)
Figure 28. Europe Hospital Injectable Drugs Market Share by Application (2016-2027)
Figure 29. Europe Hospital Injectable Drugs Market Share by Country (2016-2027)
Figure 30. Germany Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Hospital Injectable Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Hospital Injectable Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Hospital Injectable Drugs Market Share by Region (2016-2027)
Figure 40. China Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Hospital Injectable Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Hospital Injectable Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Hospital Injectable Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Hospital Injectable Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Hospital Injectable Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Hospital Injectable Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Hospira (Pfizer Inc.) Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021)
Figure 60. Baxter Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021)
Figure 61. Fresenius Kabi Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021)
Figure 62. Sandoz (Novartis) Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021)
Figure 63. Hikma Pharmaceuticals PLC Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021)
Figure 64. Dr. Reddy’s Laboratories Ltd Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021)
Figure 65. Grifols Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021)
Figure 66. Nichi-Iko Group (Sagent) Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021)
Figure 67. Teva Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021)
Figure 68. Otsuka Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021)
Figure 69. B.Braun Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021)
Figure 70. JW Life Science Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021)
Figure 71. Auromedics Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021)
Figure 72. Sanofi Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021)
Figure 73. Gland Pharma Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021)
Figure 74. Endo International PLC Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021)
Figure 75. Sichuan Kelun Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021)
Figure 76. Cisen Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021)
Figure 77. Shijiazhuang No. 4 Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021)
Figure 78. Shandong Hualu Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021)
Figure 79. CR Double-Crane Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
Keyplayers in Global Hospital Injectable Drugs Market Size, Status and Forecast 2021-2027
Hospira (Pfizer Inc.)Baxter
Fresenius Kabi
Sandoz (Novartis)
Hikma Pharmaceuticals PLC
Dr. Reddy’s Laboratories Ltd
Grifols
Nichi-Iko Group (Sagent)
Teva Pharmaceutical
Otsuka
B.Braun
JW Life Science
Auromedics
Sanofi
Gland Pharma
Endo International PLC
Sichuan Kelun Pharmaceutical
Cisen Pharmaceutical
Shijiazhuang No. 4 Pharmaceutical
Shandong Hualu Pharmaceutical
CR Double-Crane
